Metrohm Process Analytics presents the 2060 Process Analyzer, an integrated solution for 24/7 online-monitoring of critical chemical parameters in industrial processes and wastewater streams. The new system is entirely modular by design enabling custom configurations for monitoring single or multiple process streams. Ultimate modularity Metrohm Process analyzers are well known for its modular configuration concept; [...]

LGC is delighted to announce the launch of its Quanterix Simoa HD-X automated analyser, thus becoming the first bioanalytical Contract Research Organisation in Europe to offer HD-X platform in a regulated environment. The HD-X - the very latest fully automated technology platform from Quanterix for developing and performing digital immunoassays – has been unveiled at [...]

HSINCHU, Taiwan -- Personal Genomics Taiwan, Inc. ("PGI"), today announced that it has filed a complaint in the U.S. District Court for the District of Delawareagainst Pacific Biosciences of California, Inc. ("PacBio"). The complaint asserts that PacBio's Sequel and Sequel II, as well as related commercialization activities by PacBio, infringe one or more claims of U.S. Patent No. 7,767,441 (the [...]

The Onyx™ platform enables scientists to create libraries of millions of precisely engineered single cells in one experiment through a fully automated workflow Inscripta, Inc., today announced the launch of the Onyx™ Digital Genome Engineering platform, the world’s first fully automated benchtop instrument for genome-scale engineering. The CRISPR-mediated, massively parallel platform — which includes software, consumables, instrument, and assays — enables [...]

SAN DIEGO — Molecular Assemblies, Inc., today announced that it has raised a $12.2 million Series A financing led by iSelect Fund and joined by existing investors, Agilent Technologies, Alexandria Venture Investments, and Keshif Ventures. The proceeds of the financing will be used to advance the company’s proprietary enzymatic DNA synthesis technology to power DNA-based products [...]

  Shimadzu Corporation, in partnership with the Enabling Technologies Consortiumâ„¢ (ETC), announces the release of the Nexera Preparative Supercritical Fluid Chromatography System, “Nexera UC Prep”. This next-generation prep SFC system provides the pharmaceutical industry with reliable high-performance semi-prep purification. The Nexera UC Prep is part of Shimadzu Nexera UC platform, which accommodates a wide variety [...]

Spanning Duke University and Duke Health, the Center for Advanced Genomic Technologies will use homegrown tools and techniques to discover potential therapies for human diseases from autism to cancer to schizophrenia The Duke Center for Advanced Genomic Technologies aims to investigate and re-engineer the inner workings of cellular gene regulation machinery and networks In an [...]

Syrris has upgraded the touchscreen firmware for its popular Atlas HD jacketed reactor systems to offer many of the advanced automation features previously only available using the system’s PC-based control software. These enhanced automation options – such as pH-controlled and temperature-dependent dosing – add to the system’s existing functionality to offer even greater flexibility in protocol design. The firmware upgrade expands the system’s touchscreen functionality, allowing users to review reaction protocols at a glance, monitorreactions with real-time data and graphing, and change reaction conditions [...]

Collaboration Aims to Combine the Benefits of GATK Suite and DRAGEN Bio-IT Platform To Create Best-in-Class Open-Source Software for Secondary Genomic Analysis SAN DIEGO--Illumina, Inc. (NASDAQ: ILMN) and the Broad Institute of MIT and Harvard today announced they have entered into a collaboration for the co-development of secondary genomic analysis algorithms and software. Top data scientists [...]

Glenmark signs full commercial-use license for Horizon’s gene-edited CHO cells Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the full commercial licensing to Glenmark Pharmaceuticals, a global innovative pharmaceutical company, of its gene-edited Glutamine Synthetase (“GS”) [...]